Your browser doesn't support javascript.
loading
Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A.
Wu, Runhui; Wang, Xiaoling; Zhao, Xielan; Cheng, Yanli; Zhou, Zeping; Sun, Jing; Xu, Ming; Li, Wenqian; Xiao, Jianwen; Yang, Fenge; Chen, Yun; Xu, Weiqun; Huang, Jing; Ma, Chuanrong; Gai, Wenlin; Xie, Liangzhi; Yang, Renchi.
Afiliação
  • Wu R; Beijing, Children's Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Wang X; Beijing, Children's Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Zhao X; Xiangya Hospital Central South University, Hunan, People's Republic of China.
  • Cheng Y; Shanxi Provincial Children's Hospital, Shanxi, People's Republic of China.
  • Zhou Z; The Second Affiliated Hospital of Kunming Medical University, Yunnan, People's Republic of China.
  • Sun J; Nanfang Hospital Affiliated to Southern Medical University, Guangdong, People's Republic of China.
  • Xu M; Chengdu Women's & Children's Central Hospital, Sichuan, People's Republic of China.
  • Li W; Qinghai Provincial People's Hospital, Qinghai, People's Republic of China.
  • Xiao J; The Affiliated Children's Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
  • Yang F; Fujian Medical University Union Hospital, Fujian, People's Republic of China.
  • Chen Y; Jinan Central Hospital, Shandong, People's Republic of China.
  • Xu W; The Affiliated Children's Hospital of Zhejiang Medical University, Zhejiang, People's Republic of China.
  • Huang J; The Affiliated Hospital of Guizhou Medical University, Guangdong, People's Republic of China.
  • Ma C; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, People's Republic of China.
  • Gai W; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, People's Republic of China.
  • Xie L; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, People's Republic of China.
  • Yang R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Haemophilia ; 28(6): e199-e208, 2022 Nov.
Article em En | MEDLINE | ID: mdl-35802040
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator VIII / Hemofilia A Tipo de estudo: Etiology_studies Limite: Child / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator VIII / Hemofilia A Tipo de estudo: Etiology_studies Limite: Child / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article